Tabotabo, Baby Girl .
HRN: 24-86-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/12/2024
04/19/2024
IV
30mg
Q24H
Potentially Septic Newborn
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes